Evidence map›Paper›PMID 40479714›Full record

ArticleNucleic acids research2025

Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling.

Krystal A Orlando, Sara A Grimm, Paul A Wade

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. ATAC-seq and MNase-seq Detect Distinct Modes of Chromatin Accessibility.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krystal A OrlandoEpigenetics and RNA Biology Laboratory, NIEHS, Research Triangle Park, NC, 27709, United States.ORCID 0000-0001-5790-8843
Sara A GrimmBiostatistics and Computational Biology Branch, NIEHS, Research Triangle Park, NC, 27709, United States.ORCID 0000-0003-3050-1909
Paul A WadeEpigenetics and RNA Biology Laboratory, NIEHS, Research Triangle Park, NC, 27709, United States.ORCID 0000-0002-6042-357X

Funding

NIEHS NIH HHSNIH HHS ES101965
6 · The paper itself

Abstract

Pioneer transcription factors (PTFs) bind to inaccessible chromatin and recruit collaborating transcription factors to promote chromatin accessibility. However, mechanisms driving PTFs to specify collaborating transcription factor recruitment and chromatin remodeling remain unclear. Here, we utilize inducible expression of a PTF, GATA3, in a basal breast cancer cell line (SUM159PT) to mechanistically address the collaborating transcription factor requirements and the local chromatin architecture delineating GATA3-depenent chromatin accessibility and enhancer formation (productive sites) versus GATA3-bound inaccessible chromatin (unproductive sites). Transcription factor footprinting in productive sites illustrated enrichment of GATA3 with AP-1 transcription factor. Together, GATA3 and AP-1 colocalize at primed enhancers with p300 and BRG1 where nucleosome positioning is influenced by GATA3 binding. Although inhibition of AP-1 binding affects a small subset of productive sites, we demonstrate that inhibition of SWI/SNF ATPases results in dramatic loss of GATA3-dependent chromatin accessibility, binding, and alterations in local chromatin architecture. We conclude that GATA3-dependent gains in chromatin accessibility require chromatin remodeling and that accessibility at some loci is facilitated by collaborating transcription factors like AP-1.

Indexed as

Chromatin Assembly and DisassemblyEnhancer Elements, GeneticGATA3 Transcription FactorTranscription FactorsBinding SitesCell Line, TumorChromatinDNA HelicasesHumansNuclear ProteinsNucleosomesProtein BindingTranscription Factor AP-1ChromatinDNA HelicasesGATA3 protein, humanGATA3 Transcription FactorNuclear ProteinsNucleosomesSMARCA4 protein, humanTranscription Factor AP-1Transcription Factors

Identifiers

PMID40479714
PMCPMC12143596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.